HIV drug resistance study for people with viral failure
Part of Immune system & allergy, Infections clinical trials.
This study looks for drug-resistant HIV strains in people whose virus is not fully controlled by their current treatment. It aims to help doctors understand why the virus is still detectable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You agree to take part in the study.
- You have been on HIV treatment for at least six months.
- Your HIV viral load has been above 50 copies/mL in at least two recent blood tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different ways to manage “virologic failure,” meaning HIV viral load stays high while taking TLD (a common HIV medicine combination). It may help people better control the virus and improve treatment results, especially in parts of sub-Saharan Africa.
This trial is a registry for people with HIV whose virus is no longer fully controlled by certain newer medications (integrase inhibitors). It aims to collect data to better understand why these treatments stop working and how to improve future care.
This study looks at whether certain HIV drug resistance mutations affect how well your immune system recovers after starting HIV treatment. You may qualify if you are newly diagnosed, have never taken HIV meds before, and have a drug resistance test result available.
This study looks at how drug resistance mutations in HIV might affect how well certain treatments work, including two-drug regimens. It aims to help doctors choose the best medicines for each person.
This study looks at how HIV continues to multiply (or stays suppressed) while you are taking antiretroviral therapy, using blood samples. It may help researchers better understand what HIV is doing during treatment and why some people experience changes like viral rebound.
This is an observational study that follows people with HIV who are taking HIV medicines (antiretroviral therapy). It may help researchers understand how treatment is going and what factors relate to doing well on therapy.
Hear when a new HIV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.